Clinical Trial Update: Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the combination of bortezomib, 5-fluorouracil, and leucovorin in patients with metastatic or unresectable gastric cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• Velcade (bortezomib)

Snippet

Sponsor: California Cancer Consortium | Conditions: Gastric Cancer | Phase 2 | Status: TERMINATED